These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37890156)

  • 21. Cdx4 dysregulates Hox gene expression and generates acute myeloid leukemia alone and in cooperation with Meis1a in a murine model.
    Bansal D; Scholl C; Fröhling S; McDowell E; Lee BH; Döhner K; Ernst P; Davidson AJ; Daley GQ; Zon LI; Gilliland DG; Huntly BJ
    Proc Natl Acad Sci U S A; 2006 Nov; 103(45):16924-9. PubMed ID: 17068127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional control of leukemogenesis by the chromatin reader SGF29.
    Barbosa K; Deshpande A; Perales M; Xiang P; Murad R; Pramod AB; Minkina A; Robertson N; Schischlik F; Lei X; Sun Y; Brown A; Amend D; Jeremias I; Doench JG; Humphries RK; Ruppin E; Shendure J; Mali P; Adams PD; Deshpande AJ
    Blood; 2024 Feb; 143(8):697-712. PubMed ID: 38048593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cells.
    Schneider E; Pochert N; Ruess C; MacPhee L; Escano L; Miller C; Krowiorz K; Delsing Malmberg E; Heravi-Moussavi A; Lorzadeh A; Ashouri A; Grasedieck S; Sperb N; Kumar Kopparapu P; Iben S; Staffas A; Xiang P; Rösler R; Kanduri M; Larsson E; Fogelstrand L; Döhner H; Döhner K; Wiese S; Hirst M; Keith Humphries R; Palmqvist L; Kuchenbauer F; Rouhi A
    Leukemia; 2020 May; 34(5):1253-1265. PubMed ID: 31768018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HOX expression patterns identify a common signature for favorable AML.
    Andreeff M; Ruvolo V; Gadgil S; Zeng C; Coombes K; Chen W; Kornblau S; Barón AE; Drabkin HA
    Leukemia; 2008 Nov; 22(11):2041-7. PubMed ID: 18668134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular synergy underlies the co-occurrence patterns and phenotype of
    Dovey OM; Cooper JL; Mupo A; Grove CS; Lynn C; Conte N; Andrews RM; Pacharne S; Tzelepis K; Vijayabaskar MS; Green P; Rad R; Arends M; Wright P; Yusa K; Bradley A; Varela I; Vassiliou GS
    Blood; 2017 Oct; 130(17):1911-1922. PubMed ID: 28835438
    [No Abstract]   [Full Text] [Related]  

  • 26. Meis1 programs transcription of FLT3 and cancer stem cell character, using a mechanism that requires interaction with Pbx and a novel function of the Meis1 C-terminus.
    Wang GG; Pasillas MP; Kamps MP
    Blood; 2005 Jul; 106(1):254-64. PubMed ID: 15755900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Menin inhibitor MI-3454 induces remission in MLL1-rearranged and NPM1-mutated models of leukemia.
    Klossowski S; Miao H; Kempinska K; Wu T; Purohit T; Kim E; Linhares BM; Chen D; Jih G; Perkey E; Huang H; He M; Wen B; Wang Y; Yu K; Lee SC; Danet-Desnoyers G; Trotman W; Kandarpa M; Cotton A; Abdel-Wahab O; Lei H; Dou Y; Guzman M; Peterson L; Gruber T; Choi S; Sun D; Ren P; Li LS; Liu Y; Burrows F; Maillard I; Cierpicki T; Grembecka J
    J Clin Invest; 2020 Feb; 130(2):981-997. PubMed ID: 31855575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin.
    Garzon R; Garofalo M; Martelli MP; Briesewitz R; Wang L; Fernandez-Cymering C; Volinia S; Liu CG; Schnittger S; Haferlach T; Liso A; Diverio D; Mancini M; Meloni G; Foa R; Martelli MF; Mecucci C; Croce CM; Falini B
    Proc Natl Acad Sci U S A; 2008 Mar; 105(10):3945-50. PubMed ID: 18308931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endogenous Tumor Suppressor microRNA-193b: Therapeutic and Prognostic Value in Acute Myeloid Leukemia.
    Bhayadia R; Krowiorz K; Haetscher N; Jammal R; Emmrich S; Obulkasim A; Fiedler J; Schwarzer A; Rouhi A; Heuser M; Wingert S; Bothur S; Döhner K; Mätzig T; Ng M; Reinhardt D; Döhner H; Zwaan CM; van den Heuvel Eibrink M; Heckl D; Fornerod M; Thum T; Humphries RK; Rieger MA; Kuchenbauer F; Klusmann JH
    J Clin Oncol; 2018 Apr; 36(10):1007-1016. PubMed ID: 29432078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The stem cell-specific long noncoding RNA HOXA10-AS in the pathogenesis of KMT2A-rearranged leukemia.
    Al-Kershi S; Bhayadia R; Ng M; Verboon L; Emmrich S; Gack L; Schwarzer A; Strowig T; Heckl D; Klusmann JH
    Blood Adv; 2019 Dec; 3(24):4252-4263. PubMed ID: 31867596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells.
    Kawagoe H; Humphries RK; Blair A; Sutherland HJ; Hogge DE
    Leukemia; 1999 May; 13(5):687-98. PubMed ID: 10374871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linkage of the potent leukemogenic activity of Meis1 to cell-cycle entry and transcriptional regulation of cyclin D3.
    Argiropoulos B; Yung E; Xiang P; Lo CY; Kuchenbauer F; Palmqvist L; Reindl C; Heuser M; Sekulovic S; Rosten P; Muranyi A; Goh SL; Featherstone M; Humphries RK
    Blood; 2010 May; 115(20):4071-82. PubMed ID: 20237320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TGIF1 is a negative regulator of MLL-rearranged acute myeloid leukemia.
    Willer A; Jakobsen JS; Ohlsson E; Rapin N; Waage J; Billing M; Bullinger L; Karlsson S; Porse BT
    Leukemia; 2015 May; 29(5):1018-31. PubMed ID: 25349154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preclinical efficacy of the potent, selective menin-KMT2A inhibitor JNJ-75276617 (bleximenib) in KMT2A- and NPM1-altered leukemias.
    Kwon MC; Thuring JW; Querolle O; Dai X; Verhulst T; Pande V; Marien A; Goffin D; Wenge DV; Yue H; Cutler JA; Jin C; Perner F; Hogeling SM; Shaffer PL; Jacobs F; Vinken P; Cai W; Keersmaekers V; Eyassu F; Bhogal B; Verstraeten K; El Ashkar S; Perry JA; Jayaguru P; Barreyro L; Kuchnio A; Darville N; Krosky D; Urbanietz G; Verbist B; Edwards JP; Cowley GS; Kirkpatrick R; Steele R; Ferrante L; Guttke C; Daskalakis N; Pietsch EC; Wilson DM; Attar R; Elsayed Y; Fischer ES; Schuringa JJ; Armstrong SA; Packman K; Philippar U
    Blood; 2024 Sep; 144(11):1206-1220. PubMed ID: 38905635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistence of
    Harrop S; Nguyen PC; Byrne D; Wilson C; Ryland GL; Nguyen T; Anderson MA; Khaw SL; Martin M; Tiong IS; Sanij E; Blombery P
    EJHaem; 2023 Nov; 4(4):1105-1109. PubMed ID: 38024622
    [No Abstract]   [Full Text] [Related]  

  • 36. CTCF boundary remodels chromatin domain and drives aberrant
    Luo H; Wang F; Zha J; Li H; Yan B; Du Q; Yang F; Sobh A; Vulpe C; Drusbosky L; Cogle C; Chepelev I; Xu B; Nimer SD; Licht J; Qiu Y; Chen B; Xu M; Huang S
    Blood; 2018 Aug; 132(8):837-848. PubMed ID: 29760161
    [No Abstract]   [Full Text] [Related]  

  • 37. Upregulation of Meis1 and HoxA9 in acute lymphocytic leukemias with the t(4 : 11) abnormality.
    Rozovskaia T; Feinstein E; Mor O; Foa R; Blechman J; Nakamura T; Croce CM; Cimino G; Canaani E
    Oncogene; 2001 Feb; 20(7):874-8. PubMed ID: 11314021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell of origin in AML: susceptibility to MN1-induced transformation is regulated by the MEIS1/AbdB-like HOX protein complex.
    Heuser M; Yun H; Berg T; Yung E; Argiropoulos B; Kuchenbauer F; Park G; Hamwi I; Palmqvist L; Lai CK; Leung M; Lin G; Chaturvedi A; Thakur BK; Iwasaki M; Bilenky M; Thiessen N; Robertson G; Hirst M; Kent D; Wilson NK; Göttgens B; Eaves C; Cleary ML; Marra M; Ganser A; Humphries RK
    Cancer Cell; 2011 Jul; 20(1):39-52. PubMed ID: 21741595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern.
    Hollink IH; van den Heuvel-Eibrink MM; Arentsen-Peters ST; Pratcorona M; Abbas S; Kuipers JE; van Galen JF; Beverloo HB; Sonneveld E; Kaspers GJ; Trka J; Baruchel A; Zimmermann M; Creutzig U; Reinhardt D; Pieters R; Valk PJ; Zwaan CM
    Blood; 2011 Sep; 118(13):3645-56. PubMed ID: 21813447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AbdB-like Hox proteins stabilize DNA binding by the Meis1 homeodomain proteins.
    Shen WF; Montgomery JC; Rozenfeld S; Moskow JJ; Lawrence HJ; Buchberg AM; Largman C
    Mol Cell Biol; 1997 Nov; 17(11):6448-58. PubMed ID: 9343407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.